Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Atazanavir-ritonavir on the Pharmacokinetics and Toxicity of Lumefantrine in People Living With HIV Attending Lagos University Teaching Hospital

NCT04531072 is registered in ClinicalTrials.gov with Fogarty International Center of the National Institute of Health as lead sponsor.

NCT NCT04531072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04531072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Atazanavir-ritonavir on the Pharmacokinetics and Toxicity of Lumefantrine in People Living With HIV Attending Lagos University Teaching Hospital
Lead sponsor
Fogarty International Center of the National Institute of Health
Phase
Phase 4
Overall status
Completed
Start date
September 18, 2018
Completion date
August 15, 2019
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug interaction